Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 19, 2008
[Splenic marginal zone B-cell lymphoma with bilateral renal invasion after splenectomy]Takumi Hoshino, Hirono Iriuchijima, Yoshiyuki Ogawa, et al.Paediatric Anaesthesia|March 28, 2008
Prolonged sevoflurane inhalation therapy for status asthmaticus in an infantKazuhiro Watanabe, Taro Mizutani, Soichiro Yamashita, et al.Journal of Pediatric Surgery|August 17, 2011
Enteric duplication cyst of the pancreas with duplicated pancreatic ductJun Fujishiro, Michio Kaneko, Yasuhisa Urita, et al.Pediatric Radiology|May 17, 2008
Type I biliary atresia without extrahepatic biliary cystHiroaki Komuro, Toyoichiro Kudo, Takahiro Jinbo, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2014
Clinical experience of bendamustine for adult Langerhans cell sarcomaYuri Miyazawa, Kenichi Tahara, Akinori Yuzuriha, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 18, 2007
[Chronic eosinophilic leukemia with symptoms resembling Budd-Chiari syndrome due to liver infiltration]Hirono Iriuchishima, Yoshiyuki Ogawa, Takumi Hoshino, et al.Journal of Medicine|August 9, 2007
Combination chemotherapy of ranimustine, doxorubicine, and dexamethasone for relapsing multiple myeloma--a pilot studyHirokazu Murakami, Arito Yamane, Morio Sawamura, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 3, 2003
[Treatment outcome of myelodysplastic syndrome patients younger than 60 years old]Takafumi Matsushima, Hiroshi Handa, Akihiko Yokohama, et al.International Journal of Hematology|November 22, 2015
SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patientsTakeki Mitsui, Hiromi Koiso, Hirotaka Nakahashi, et al.Journal of Clinical and Experimental Hematopathology : JCEH|December 27, 2013
Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 casesYoko Hashimoto, Akihiko Yokohama, Akio Saitoh, et al.Pageof 2